Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

• Status: Completed
• Trial end date: 2013-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This observational study is conducted in Europe. The aim of this non-interventional (observational) study is to evaluate the efficacy of liraglutide (Victoza®) and to assess the conditions of use of Victoza® in daily medical practice in France.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Liraglutide

Criteria

Inclusion Criteria:

• Patients diagnosed with type 2 diabetes

• Patients having recently started (for less than one week) or starting liraglutide (Victoza®) treatment

Exclusion Criteria:

• Hypersensitivity (allergy) to liraglutide or to any of the excipients

• Patient is participating in a clinical trial at the inclusion

• Type 1 diabetes